Gary Reynolds
Overview
Explore the profile of Gary Reynolds including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
4126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Acharjee A, Shivaji U, Santacroce G, Akiror S, Jeffery L, Varnai C, et al.
Inflamm Bowel Dis
. 2025 Feb;
PMID: 39977234
Background: Fibrosis is a common complication in Crohn's disease (CD), often leading to intestinal strictures. This study aims to explore the transcriptomic signature of fibrostenotic ileal CD for a comprehensive...
2.
Li R, Strobl J, Poyner E, Balbaa A, Torabi F, Mazin P, et al.
Nat Immunol
. 2024 Dec;
26(1):147.
PMID: 39622949
No abstract available.
3.
Li R, Strobl J, Poyner E, Balbaa A, Torabi F, Mazin P, et al.
Nat Immunol
. 2024 Nov;
25(12):2320-2330.
PMID: 39558094
Cutaneous T cell lymphoma (CTCL) is a potentially fatal clonal malignancy of T cells primarily affecting the skin. The most common form of CTCL, mycosis fungoides, can be difficult to...
4.
Devine H, Bhatnagar P, Chambers A, Ledingham D, Bolton C, Reynolds G, et al.
Pract Neurol
. 2024 Oct;
25(1):84-86.
PMID: 39461875
No abstract available.
5.
Gopee N, Winheim E, Olabi B, Admane C, Foster A, Huang N, et al.
Nature
. 2024 Oct;
635(8039):679-689.
PMID: 39415002
Human prenatal skin is populated by innate immune cells, including macrophages, but whether they act solely in immunity or have additional functions in morphogenesis is unclear. Here we assembled a...
6.
McLean A, Reynolds G, Pratt A
Biomedicines
. 2024 Jun;
12(6).
PMID: 38927506
The observation that certain therapeutic strategies for targeting inflammation benefit patients with distinct immune-mediated inflammatory diseases (IMIDs) is exemplified by the success of TNF blockade in conditions including rheumatoid arthritis,...
7.
Borrego-Yaniz G, Ortiz-Fernandez L, Madrid-Paredes A, Kerick M, Hernandez-Rodriguez J, Mackie S, et al.
Lancet Rheumatol
. 2024 May;
6(6):e374-e383.
PMID: 38734017
Background: Giant cell arteritis is an age-related vasculitis that mainly affects the aorta and its branches in individuals aged 50 years and older. Current options for diagnosis and treatment are...
8.
Karabayas M, Ibrahim H, Roelofs A, Reynolds G, Kidder D, De Bari C
Ann Rheum Dis
. 2024 Apr;
83(9):1100-1109.
PMID: 38684323
Giant cell arteritis (GCA), the most common systemic vasculitis, is characterised by aberrant interactions between infiltrating and resident cells of the vessel wall. Ageing and breach of tolerance are prerequisites...
9.
Toyoda T, Armitstead Z, Bhide S, Engamba S, Henderson E, Jones C, et al.
Rheumatol Adv Pract
. 2024 Feb;
8(1):rkae002.
PMID: 38371294
The last British Society for Rheumatology (BSR) guideline on PMR was published in 2009. The guideline needs to be updated to provide a summary of the current evidence for pharmacological...
10.
Negri V, Louis B, Zijl S, Ganier C, Philippeos C, Ali S, et al.
Stem Cell Reports
. 2023 Oct;
18(11):2047-2055.
PMID: 37832539
Single-cell RNA sequencing (scRNA-seq) of human skin provides a tool for validating observations from in vitro experimental models. By analyzing a published dataset of healthy adult epidermis, we confirm that...